Annual EBIT
-$12.41 M
+$1.28 M+9.32%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual earnings before interest & taxes is -$12.41 million, with the most recent change of +$1.28 million (+9.32%) on December 1, 2023.
- During the last 3 years, KPRX annual EBIT has fallen by -$5.57 million (-81.32%).
- KPRX annual EBIT is now -1018.44% below its all-time high of -$1.11 million, reached on December 31, 2014.
Performance
KPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.70 M
-$273.50 K-11.28%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly earnings before interest & taxes is -$2.70 million, with the most recent change of -$273.50 thousand (-11.28%) on September 1, 2024.
- Over the past year, KPRX quarterly EBIT has dropped by -$197.30 thousand (-7.89%).
- KPRX quarterly EBIT is now -120.43% below its all-time high of $13.21 million, reached on March 1, 2024.
Performance
KPRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$2.37 M
-$197.30 K-7.68%
September 1, 2024
Summary
- As of February 8, 2025, KPRX TTM earnings before interest & taxes is $2.37 million, with the most recent change of -$197.30 thousand (-7.68%) on September 1, 2024.
- Over the past year, KPRX TTM EBIT has increased by +$14.65 million (+119.32%).
- KPRX TTM EBIT is now -7.68% below its all-time high of $2.57 million, reached on June 1, 2024.
Performance
KPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KPRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.3% | -7.9% | +119.3% |
| 3 y3 years | -81.3% | -8.4% | +118.0% |
| 5 y5 years | -15.7% | -8.4% | +118.0% |
KPRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.1% | -120.4% | +52.8% | -7.7% | +117.2% |
| 5 y | 5-year | -81.3% | +11.1% | -120.4% | +52.8% | -7.7% | +117.2% |
| alltime | all time | -1018.4% | +14.7% | -120.4% | +52.8% | -7.7% | +116.3% |
Kiora Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.70 M(+11.3%) | $2.37 M(-7.7%) |
| Jun 2024 | - | -$2.42 M(-118.4%) | $2.57 M(+2.6%) |
| Mar 2024 | - | $13.21 M(-331.2%) | $2.51 M(-120.2%) |
| Dec 2023 | -$12.41 M(-9.3%) | -$5.71 M(+128.5%) | -$12.41 M(+1.1%) |
| Sep 2023 | - | -$2.50 M(+0.5%) | -$12.28 M(-6.6%) |
| Jun 2023 | - | -$2.49 M(+45.8%) | -$13.14 M(+0.9%) |
| Mar 2023 | - | -$1.71 M(-69.4%) | -$13.02 M(-4.9%) |
| Dec 2022 | -$13.69 M(-1.9%) | -$5.58 M(+65.8%) | -$13.69 M(-0.6%) |
| Sep 2022 | - | -$3.37 M(+42.1%) | -$13.77 M(+3.0%) |
| Jun 2022 | - | -$2.37 M(-0.2%) | -$13.37 M(-1.3%) |
| Mar 2022 | - | -$2.37 M(-58.1%) | -$13.54 M(+2.8%) |
| Dec 2021 | -$13.96 M(+103.9%) | -$5.66 M(+90.9%) | -$13.18 M(+51.7%) |
| Sep 2021 | - | -$2.97 M(+16.8%) | -$8.69 M(+12.4%) |
| Jun 2021 | - | -$2.54 M(+26.4%) | -$7.73 M(+11.9%) |
| Mar 2021 | - | -$2.01 M(+71.9%) | -$6.90 M(+0.8%) |
| Dec 2020 | -$6.85 M(-2.2%) | -$1.17 M(-41.7%) | -$6.85 M(-17.4%) |
| Sep 2020 | - | -$2.01 M(+16.9%) | -$8.28 M(-14.6%) |
| Jun 2020 | - | -$1.72 M(-12.0%) | -$9.70 M(-1.2%) |
| Mar 2020 | - | -$1.95 M(-25.1%) | -$9.82 M(+40.3%) |
| Dec 2019 | -$7.00 M(-34.7%) | -$2.61 M(-24.0%) | -$7.00 M(+2.4%) |
| Sep 2019 | - | -$3.43 M(+86.6%) | -$6.84 M(+4.7%) |
| Jun 2019 | - | -$1.84 M(-311.0%) | -$6.53 M(-12.6%) |
| Mar 2019 | - | $870.90 K(-135.7%) | -$7.47 M(-30.3%) |
| Dec 2018 | -$10.72 M | -$2.44 M(-21.8%) | -$10.72 M(-13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$3.12 M(+12.4%) | -$12.46 M(-7.5%) |
| Jun 2018 | - | -$2.78 M(+16.9%) | -$13.47 M(-3.9%) |
| Mar 2018 | - | -$2.38 M(-43.0%) | -$14.02 M(-3.7%) |
| Dec 2017 | -$14.56 M(+9.1%) | -$4.17 M(+0.8%) | -$14.56 M(+3.3%) |
| Sep 2017 | - | -$4.14 M(+24.5%) | -$14.09 M(+5.7%) |
| Jun 2017 | - | -$3.33 M(+13.9%) | -$13.32 M(-3.6%) |
| Mar 2017 | - | -$2.92 M(-21.1%) | -$13.82 M(+3.6%) |
| Dec 2016 | -$13.34 M(+106.8%) | -$3.70 M(+9.6%) | -$13.34 M(+8.3%) |
| Sep 2016 | - | -$3.38 M(-11.7%) | -$12.32 M(+19.6%) |
| Jun 2016 | - | -$3.82 M(+56.5%) | -$10.30 M(+28.5%) |
| Mar 2016 | - | -$2.44 M(-8.7%) | -$8.01 M(+24.2%) |
| Dec 2015 | -$6.45 M(+481.5%) | -$2.68 M(+97.6%) | -$6.45 M(+63.3%) |
| Sep 2015 | - | -$1.35 M(-12.2%) | -$3.95 M(+90.2%) |
| Jun 2015 | - | -$1.54 M(+75.0%) | -$2.08 M(+85.4%) |
| Mar 2015 | - | -$880.90 K(+405.4%) | -$1.12 M(+0.9%) |
| Dec 2014 | -$1.11 M(-63.9%) | -$174.30 K(-133.5%) | -$1.11 M(-28.5%) |
| Sep 2014 | - | $520.10 K(-188.9%) | -$1.55 M(-43.9%) |
| Jun 2014 | - | -$584.80 K(-32.8%) | -$2.77 M(-6.3%) |
| Mar 2014 | - | -$870.80 K(+41.2%) | -$2.95 M(-3.8%) |
| Dec 2013 | -$3.07 M(-47.1%) | -$616.70 K(-11.2%) | -$3.07 M(+25.1%) |
| Sep 2013 | - | -$694.80 K(-9.9%) | -$2.45 M(+39.5%) |
| Jun 2013 | - | -$770.90 K(-22.0%) | -$1.76 M(+78.0%) |
| Mar 2013 | - | -$988.90 K | -$988.90 K |
| Dec 2012 | -$5.81 M | - | - |
FAQ
- What is Kiora Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual EBIT year-on-year change?
- What is Kiora Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly EBIT year-on-year change?
- What is Kiora Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals TTM EBIT year-on-year change?
What is Kiora Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of KPRX is -$12.41 M
What is the all time high annual EBIT for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual earnings before interest & taxes is -$1.11 M
What is Kiora Pharmaceuticals annual EBIT year-on-year change?
Over the past year, KPRX annual earnings before interest & taxes has changed by +$1.28 M (+9.32%)
What is Kiora Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of KPRX is -$2.70 M
What is the all time high quarterly EBIT for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly earnings before interest & taxes is $13.21 M
What is Kiora Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, KPRX quarterly earnings before interest & taxes has changed by -$197.30 K (-7.89%)
What is Kiora Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of KPRX is $2.37 M
What is the all time high TTM EBIT for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high TTM earnings before interest & taxes is $2.57 M
What is Kiora Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, KPRX TTM earnings before interest & taxes has changed by +$14.65 M (+119.32%)